Km. Gronlund et al., CHRONIC SEIZURES INCREASE GLUCOSE-TRANSPORTER ABUNDANCE IN RAT-BRAIN, Journal of neuropathology and experimental neurology, 55(7), 1996, pp. 832-840
Pentylenetetrazole and kainic acid, seizure-inducing agents that are k
nown to increase glucose utilization in brain, were used to produce ch
ronic seizures in mature rats. To test the hypothesis that increased b
rain glucose utilization associated with seizures may alter glucose tr
ansporter expression, polyclonal carboxyl-terminal antisera to glucose
transporters (GLUT1 and GLUT3) were employed with a quantitative immu
nocytochemical method and immunoblots to detect changes in the regiona
l abundances of these proteins. GLUT3 abundances in control rats were
found to be correlated with published values for regional glucose util
ization in normal brain. Following treatment with kainic acid and pent
ylenetetrazole, both GLUT3 and GLUT1 increased in abundance in a regio
n and isoform-specific manner. GLUT3 was maximal at eight hours, where
as GLUT1 was maximal at three days. Immunoblots indicated that most of
the GLUT3 increase was accounted for by the higher molecular weight c
omponent of the GLUT3 doubler. The rapid response time for GLUT3 relat
ive to GLUT1 may be related to the rapid increase in neuronal metaboli
c energy demands during seizure. These observations support the hypoth
esis that glucose transporters may be upregulated in brain under condi
tions when brain glucose metabolism is elevated.